Cytokine Signalling Forum

Prof Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great efficacy and safety data on JAK inhibitors from Professors Kevin Winthrop, Stanely Cohen, Ernest Choy and Rene Westhovens.

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great new developments in cytokine signalling abstracts from Professors Iain McInnes, Xenfon Baraliakos and Maya Buch.

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great bone and patient outcomes abstracts from Professors Rieke Alten, Vibeke Strand and Zoltan Szekanecz.

Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great vaccinations and JAK inhibitors abstracts from Professor Kevin Winthrop and Dr Rodriguez-Garcia.

Dr Gustavo Citera, Head of Rheumatology at the Institute of Psychophysical Rehabilitation, Buenos Aires, Argentina. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Gustavo Citera discusses how JAK inhibition could be associated with interstitial lung disease events

Prof Leonard Calabrese presents the Day 4 highlights of the key abstracts and posters presented at ACR 2020.

Prof Leaonard Calabrese presents Day 4 highlights of the key abstracts and posters presented at ACR 2020.

Prof Christopher Ritchlin presents Day 3 highlights of the key abstracts and posters presented at ACR 2020.

Prof Christopher Ritchlin presents Day 3 highlights of the key abstracts and posters presented at ACR 2020.

Prof Christopher Edwards presents Day 2 highlights of the key abstracts and posters presented at ACR 2020.

Prof Christopher Edwards presents Day 2highlights of the key abstracts and posters presented at ACR 2020.

Prof Leonard Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2020.

Prof Leonard Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2020.

Prof Iain McInnes discusses the use of baricitinib to treat COVID-19 and a JAK inhibitor, itacitinib. Keep up-to-date with the latest information in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

A preview of the latest research at ACR 2020. Prof Edwards highlights important abstracts in cytokine signalling at the upcoming ACR Convergence.

Professor of Rheumatology at University Medical Centre, Utrecht. In this podcast, Professor Bijlsma discusses what attracted him to the field of rheumatology, the major advances in immunological knowledge leading to tsDMARDs and the importance of Treat-to-Target. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research, and views on developments in inflammation.

Professor of Rheumatology in the Department of Internal Medicine - Hospital de Clínicas at the Federal University of Paraná, Brazil. In this podcast, Professor Azevedo discusses what attracted him to rheumatology and how biosimilars have evolved in Latin America. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Kevin Winthrop, Professor of infectious diseases and public health at the Oregon Health & Science University in Portland, Oregon. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Kevin Winthrop discusses infections in baricitinib clinical trials for patients with active RA.

Dr Pedro López-Romero, a senior research scientist from Lilly, and Dr Eugen Feist from the Charité. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, they discuss anti-CarbV and anti-MCV titres as predictors for improvements in SDAI score and radiographic progression in patients with RA.